Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!
Medicine for treating cerebral thrombosis and preparing method thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of cerebral thrombosis and medicine, which is applied in the field of medicine for the treatment of cerebral thrombosis and its preparation, can solve the problems of antibody weakening and blood flow disorder, and achieve the effect of enhancing the body's cellular immune function and reducing the aggregation of red blood cells
Inactive Publication Date: 2010-06-02
肖永雪
View PDF1 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The other is that some thrombolytic sedatives inhibit the cerebral cortex, and anticoagulants cause fatty degeneration and cholesterol deposition in the deep layer of the arterial intima, forming blood flow obstacles, affecting the brain tissue within the scope of its blood supply, because of insufficient collateral circulation And softening necrosis occurs, inducing artificial antibody weakening
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0026] Powder 40g of Panax notoginseng into 120 mesh fine powder, 1.5g of borneol into 120 mesh fine powder, 70g of Bupleurum bupleuri, 90g of Chuanxiong, 70g of salvia miltiorrhiza, 150g of astragalus, 80g of earthworm, 50g of turmeric, 140g of pitted hawthorn and cut into pieces Add 1000g of water and decoct three times, decoct for one hour each time, take the juice and filter, combine the liquid together, concentrate and dry, grind into 120 mesh fine powder, then add Panax notoginseng and borneol fine powder, mix well, and pack into 0.5g capsules. become.
Embodiment 2
[0028] Powder 45g of Panax notoginseng into 120 mesh fine powder, grind 2g of borneol into 120 mesh fine powder, 80g of Bupleurum bupleuri, 100g of Chuanxiong, 80g of salvia miltiorrhiza, 160g of astragalus, 90g of earthworm, 60g of turmeric, 150g of pitted hawthorn and cut into pieces each time Add 1000g of water and decoct three times, decocting for one hour each time, take the juice and filter, combine the liquid together, concentrate and dry, grind into 120 mesh fine powder, then add Sanqi and borneol fine powder, mix well, divide into 0.5g capsules and serve .
Embodiment 3
[0030] Powder 50g of Panax notoginseng into 120 mesh fine powder, grind 2.5g of borneol into 120 mesh fine powder, 90g of Bupleurum bupleuri, 110g of Chuanxiong, 90g of salvia miltiorrhiza, 170g of astragalus, 100g of earthworm, 70g of turmeric, 160g of pitted hawthorn and cut into pieces Add 1000g of water and decoct three times, decoct for one hour each time, take the juice and filter, combine the liquid together, concentrate and dry, grind into 120 mesh fine powder, then add Panax notoginseng and borneol fine powder, mix well, and pack into 0.5g capsules. become.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention relates to a medicine for curing cerebral thrombosis and a preparation method thereof. The medicine of the invention is prepared by raw medicines with portions according to the followingweight ratio: 70-90 portions of Bupleurum chinense DC, 90-110 portions of RhizomaChuanxiong, 70-90 portions of root of red rooted salvia, 150-170 portions of radix astragali, 80-100 portions of earthworm, 50-70 portions of radix curcumae, 140-160 portions of core-removing hawthorn, 40-50 portions of radix notoginseng and 1.5-2.5 portions of borneol. The preparation method comprises that the radixnotoginseng are ground into 120 meshes of fine powder, the borneol is ground into 120 meshes of fine powder, and the Bupleurum chinense DC, the RhizomaChuanxiong, the root of red rooted salvia, the radix astragali, the earthworm, the radix curcumae and the core-removing hawthorn are cut into chips which are decocted with 1000g water for three times and each time is decocted for one hour; the rawmaterials being decocted are extracted, filtered, compressed, dried and ground into 120 meshes of fine powder, in which the radix notoginseng fine powder and the borneol fine powder are added and mixed evenly, thus obtaining the medicine through split charging into 0.5g of capsules. The medicine of the invention can promote blood circulation by removing blood stasis, warm channels and expel cold,restore consciousness and resuscitate and resist platelet aggregation; moreover, the medicine of the invention also can replenish qi to secure the exterior, clear away heat and toxic material, nourishblood and tranquilize mind and resist thrombosis; furthermore, the medicine of the invention can relieve the depressed liver, cool blood and remove stagnation and reduce erythrocyte aggregation; themedicine further can relieve muscles and warm channels, promote salivation and activate yang, dispel wind and toxicity, relieve heart and restlessness and regenerate tissues.
Description
technical field [0001] The invention relates to a medicine for treating cerebral thrombosis, in particular to a medicine for treating cerebral thrombosis prepared from Chinese herbal medicine and a preparation method thereof. Background technique [0002] According to our several years of experience in the treatment and observation of cerebral thrombosis, we have found that although various western medicines are beautiful and quick to take effect, they have left invisible hidden dangers for many people. For example: Cerebral arteriosclerosis, the patient began to use western medicine to relieve the symptoms, every time the onset was so simple, when it was out of control, some examinations revealed that it had become an incurable cancer. To some extent, it conceals the real development of the disease. The other is that some thrombolytic sedatives inhibit the cerebral cortex, and anticoagulants cause fatty degeneration and cholesterol deposition in the deep layer of the arter...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.